[1] Thomlinson RH,Gray LH,The histological structure of some human lung cancers and the possible implications for radiotherapy.Br J Cancer,1955, 9(4):539-549.
[2] Fyles AW,Milosevic M,Wong et al.Oxygenation predicts radiation response and survival in patients with cervix cancer.Radiother Oncol,1998,48(2):149-156.
[3] Busk M,Horsman MR,Kristjansen PE,et al.Aerobic glycolysis in cancers:implications for the usability of oxygen-responsive genes and fluorodeoxyglucose-PET as markers of tissue hypoxia.Int J Cancer,2008,122(12):2726-2734.
[4] Dierckx RA,Van de Wiele C.FDG uptake,a surrogate of tumour hypoxia?.Eur J Nucl Med Mol Imaging,2008,35(8):1544-1549.
[5] Wei W,Yu XD,Hypoxia-inducible factors:crosstalk between their protein stability and protein degradation.Cancer Lett,2007,257(2):145-156.
[6] Maloyan A,Eli-Berchoer L,Semenza GL,et al.HIF-lalpha-targeted pathways are activated by heat acclimation and contribute to acclimation-ischemic cross-tolerance in the heart.Physiol Genomics,2005,23(1):79-88.
[7] Airley RE,Mobasheri A.Hypoxic regulation of glucose transport,anaerobic metabolism and angiogenesis in cancer novel pathways and targets for anticancer therapeutics.Chemotherapy,2007,53(4):233-256.
[8] Clavo AC,Brown RS,Wahl RL.Fluorodeoxyglucose uptake in human cancer cell lines is increased by hypoxia.J Nucl Med,1995,36(9):1625-1632.
[9] Thorwarth D, Eschmann SM, Holzner F,et al Combined uptake of[18F] FDC and[18F] FMISO correlates with radiation therapy outcome in head-and-neck cancer patients.Radiother Oncol,2006,80(2):151-156.
[10] Schroeder T,Yuan H,Viglianti BL,et al.Spatial heterogeneity and oxygen dependence of glucose consumption in R3230Ac and fibrosarcomas of the Fischer 344 rat.Cancer Res,2005,65(12):5163-5171.
[11] Troost EG,Laverman P, Kaanders JH,et al.Imaging hypoxia after oxygenation-modificalion:comparing[18F] FMIS0 autoradiography with pimonidazole immunohistochemistry in human xenograft tumors.Radiother Oncol,2006,80(2):157-164.
[12] Pugachev A,Ruan S,Carlin S,et al.Dependence of FDG uptake on tumor microenvironment.Int J Radiat Oncol Biol Phys,2005,62(2):545-553.
[13] Tanaka T,Furukawa T,Fujieda S,et al.Double-tracer autoradiography with Cu-ATSM/FDG and immunohistochemical interpretation in four different mouse implanted tumor models,Nucl Med Biol,2006,33(6):743-750.
[14] Picchio M,Beck R,Haubner R,et al.Intratumoral spatial distribution of hypoxia and angiogenesis assessed by 18FAZA and 125I-Gluco-RGD autoradiography.J Nucl Med,2008,49(4):597-605.
[15] Zanzonico P,O'Donoghue J,Chapman JD,et al.Iodine-124-labeled iodo-azomycin-galactoside imaging of tumor hypoxia in mice with serial microPET scanning-Eur J Nucl Med Mol Imaging,2004,31(1):117-128.
[16] Dence CS,Ponde DE, Welch MJ,et al.Autoradiographic and small-animal PET comparisons between 18F-FMISO,18F-FDG,18F-FLT and the hypoxic selective 66Cu-ATSM in a rodent model ofcancer.Nucl Med Biol,2008, 35(6):713-720.
[17] Obata A,Yoshimoto M,Kasamatsu S,et al.Intra-tiunoral distribution of 66Cu-ATSM:a comparison study with FDG.Nucl Med Biol,2003,30(5):529-534.
[18] Wyss MT,Honer M,Schubiger PA,et al.NanoPET imaging of[18F] fluoromisonidazole uptake in experimental mouse tumours.Eur J Nucl Med Mol Imaging 2006,33(3):311-318.
[19] Zanzonico P,Carapa J,Polycarpe-Holman D,et al.Animal-specific positioning molds for registration of repeat imaging studies:comparative microPET imaging of F18-labeled fluoro-deoxyglucose and fluoro-misonidazole in rodent tumors.Nucl Med Biol,2006,33(1):65-70.